Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Researchers have modified an oncolytic virus so that it blocks the protein TGF-beta, helping expose tumors to the immune system.

Cureus, The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy

The Antiviral Apparatus: STING and Oncolytic Virus Restriction: Molecular Therapy - Oncolytics

Frontiers Oncolytic Viruses as Anticancer Vaccines

Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities

Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors

Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends

Oncolytic Virus Disrupts Immune-Blocking Protein - NCI

Enhanced T cell effector activity by targeting the Mediator kinase module

Targeting pediatric cancer stem cells with oncolytic virotherapy

Oncolytic virotherapy

Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme - Ahmed - 2023 - MedComm – Oncology - Wiley Online Library

Oncolytic virotherapy